AI assistant
Microbot Medical Inc. — Director's Dealing 2016
Jan 12, 2016
33819_dirs_2016-01-12_5e2b2d27-e72d-4e81-a8d5-12587db29394.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2016-01-08
Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-08 | Common Stock | F | 236736 | $0.38 | Acquired | 2230297 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 33745 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 350,000 restricted stock units, with 175,000 of these vesting on each of June 14, 2016 and June 14, 2017; (2) 837,000 restricted stock units, with 418,500 of these vesting on each of January 8, 2017 and January 8, 2018; and (3) 418,500 restricted stock units with performance based vesting.
F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.